Alprazolam Detection Using an Electrochemical Nanobiosensor Based on AuNUs/Fe-Ni@rGO Nanocomposite.
Emadoddin Amin SadrabadiFatemeh KhosraviAli BenvidiAmin Shiralizadeh DezfuliPouria KhashayarPatricia KhashayarMostafa AzimzadehPublished in: Biosensors (2022)
Despite all the psychological advantages of alprazolam, its long list of toxic properties and interactions has caused concern and highlighted the need for a reliable sensing method. In this study, we developed a simple, highly sensitive electrochemical nanobiosensor to determine the desirable dose of alprazolam, averting the undesirable consequences of overdose. Gold nanourchins (AuNUs) and iron-nickel reduced graphene oxide (Fe-Ni@rGO) were immobilized on a glassy carbon electrode, which was treated beforehand. The electrode surface was characterized using cyclic voltammetry, Fourier transform infrared spectroscopy, scanning electron microscopy/energy-dispersive X-ray spectroscopy, and differential pulse voltammetry. The fabricated sensor showed two linear ranges (4 to 500 µg L -1 and 1 to 50 mg L -1 ), low limit of detection (1 µg L -1 ), high sensitivity, good repeatability, and good recovery. Increased -OH and carboxyl (-COOH) groups on the electrode surface, resulting in improved the adsorption of alprazolam and thus lower limit of detection. This nanobiosensor could detect alprazolam powder dissolved in diluted blood serum; we also studied other benzodiazepine drugs (clonazepam, oxazepam, and diazepam) with this nanobiosensor, and results were sensible, with a significant difference.
Keyphrases
- reduced graphene oxide
- gold nanoparticles
- electron microscopy
- label free
- ionic liquid
- high resolution
- loop mediated isothermal amplification
- carbon nanotubes
- solid state
- real time pcr
- metal organic framework
- molecularly imprinted
- aqueous solution
- computed tomography
- visible light
- mass spectrometry
- solid phase extraction
- magnetic resonance imaging
- depressive symptoms
- gas chromatography mass spectrometry